Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome

BACKGROUND: The efficacy of tacrolimus (TAC) is variable in the treatment of nephrotic syndrome (NS), which might be related to genetic variation among patients. Therefore, we aim to investigate the effects of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of TAC in the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Min, Xu, Min, Liu, Wei, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883590/
https://www.ncbi.nlm.nih.gov/pubmed/29615122
http://dx.doi.org/10.1186/s40360-018-0202-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5883590/
https://www.ncbi.nlm.nih.gov/pubmed/29615122
http://dx.doi.org/10.1186/s40360-018-0202-9

Ejemplares similares